Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

作者: Jean-Guy Baril , Jonathan B Angel , M John Gill , Joseph Gathe , Pedro Cahn

DOI: 10.1371/JOURNAL.PONE.0148231

关键词:

摘要: Objective We reviewed the current literature regarding antiretroviral (ARV)-sparing therapy strategies to determine whether these novel regimens can be considered appropriate …

参考文章(56)
Beau M Ances, Serena S Spudich, Neurologic complications of HIV infection: highlights from the 2013 Conference on Retroviruses and Opportunistic Infections. Topics in antiviral medicine. ,vol. 21, pp. 100- 108 ,(2013)
Amit C. Achhra, Janaki Amin, Jennifer Hoy, Junko Tanuma, Thira Sirisanthana, David Nolan, Tuti Merati, Michelle Giles, Differences in Lipid Measurements by Antiretroviral Regimen Exposure in Cohorts from Asia and Australia Aids Research and Treatment. ,vol. 2012, pp. 1- 9 ,(2012) , 10.1155/2012/246280
J Allen McCutchan, Julia W Wu, Kevin Robertson, Susan L Koletar, Ronald J Ellis, Susan Cohn, Michael Taylor, Steven Woods, Robert Heaton, Judith Currier, Paige L Williams, None, HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. ,vol. 21, pp. 1109- 1117 ,(2007) , 10.1097/QAD.0B013E3280EF6ACD
Véronique Reliquet, Catherine Chirouze, Clotilde Allavena, Patrice Muret, Gilles Peytavin, Elisabeth André-Garnier, Dominique Bettinger, Virginie Ferré, Bruno Hoen, François Raffi, Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients. Antiviral Therapy. ,vol. 19, pp. 117- 123 ,(2013) , 10.3851/IMP2691
Amedeo Ferdinando Capetti, Stefania Piconi, Simona Landonio, Giuliano Rizzardini, Carlo Federico Perno, Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in Hiv-1 Infection? Journal of Acquired Immune Deficiency Syndromes. ,vol. 50, pp. 233- 234 ,(2009) , 10.1097/QAI.0B013E31818C7E8E
Richard H Haubrich, Sharon A Riddler, A Gregory DiRienzo, Lauren Komarow, William G Powderly, Karin Klingman, Kevin W Garren, David L Butcher, James F Rooney, David W Haas, John W Mellors, Diane V Havlir, AIDS Clinical Trials Group, A5142 Study Team, Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. ,vol. 23, pp. 1109- 1118 ,(2009) , 10.1097/QAD.0B013E32832B4377
Eug??nia Negredo, Jos?? Molt??, David Burger, Helene C??t??, Oscar Mir??, Josep Ribalta, Eva Mart??nez, Jordi Puig, Lidia Ruiz, Juliana Salazar, S??nia L??pez, Julio Montaner, Celestino Rey-Joly, Bonaventura Clotet, Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). Journal of Acquired Immune Deficiency Syndromes. ,vol. 38, pp. 47- 52 ,(2005) , 10.1097/00126334-200501010-00009
Sandra Mathis, Bettina Khanlari, Federico Pulido, Mauro Schechter, Eugenia Negredo, Mark Nelson, Pietro Vernazza, Pedro Cahn, Jean-Luc Meynard, Jose Arribas, Heiner C. Bucher, Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0022003
Jacques Reynes, Roger Trinh, Federico Pulido, Ruth Soto-Malave, Joseph Gathe, Roula Qaqish, Min Tian, Linda Fredrick, Thomas Podsadecki, Michael Norton, Angela Nilius, Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study. AIDS Research and Human Retroviruses. ,vol. 29, pp. 256- 265 ,(2012) , 10.1089/AID.2011.0275